SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-040322
Filing Date
2023-11-13
Accepted
2023-11-13 08:01:00
Documents
56
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 612896
2 ex31-1.htm EX-31.1 12161
3 ex31-2.htm EX-31.2 12162
4 ex31-3.htm EX-31.3 12187
5 ex32-1.htm EX-32.1 10592
  Complete submission text file 0001493152-23-040322.txt   3895426

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE cocp-20230930.xsd EX-101.SCH 33890
7 XBRL CALCULATION FILE cocp-20230930_cal.xml EX-101.CAL 42227
8 XBRL DEFINITION FILE cocp-20230930_def.xml EX-101.DEF 140557
9 XBRL LABEL FILE cocp-20230930_lab.xml EX-101.LAB 296048
10 XBRL PRESENTATION FILE cocp-20230930_pre.xml EX-101.PRE 227101
50 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 500688
Mailing Address 19805 N. CREEK PARKWAY BOTHELL WA 98011
Business Address 19805 N. CREEK PARKWAY BOTHELL WA 98011 (786) 459-1831
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38418 | Film No.: 231395237
SIC: 2834 Pharmaceutical Preparations